4//SEC Filing
Leonard Braden Michael 4
Accession 0001373604-25-000122
CIK 0001501756other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 6:20 PM ET
Size
6.0 KB
Accession
0001373604-25-000122
Insider Transaction Report
Form 4
Leonard Braden Michael
10% Owner
Transactions
- Sale
Common Stock
2025-12-04$4.19/sh−524,560$2,200,372→ 1,958,080 total(indirect: Holdings of BML Investment Partners, L.P.)
Holdings
- 191,800
Common Stock
Footnotes (2)
- [F1]BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
- [F2]Represents shares sold in multiple transactions at a price of $4.1947 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the transactions at the price sold.
Documents
Issuer
Adverum Biotechnologies, Inc.
CIK 0001501756
Entity typeother
Related Parties
1- filerCIK 0001373603
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 6:20 PM ET
- Size
- 6.0 KB